James

Floyd

MD

MS

Education & Training

• MD, Duke University, School of Medicine, Durham, NC (2005)
• MS, University of Washington, School of Public Health, Seattle, WA (2011)
• Internship and Residency in Internal Medicine, University of Washington, Seattle, WA (2005–2008)

Honors

• Duke University William J. Griffith University Service Award
• University of Washington Chair of Medicine Scholar Award
• Food and Drug Administration Drug Safety & Risk Management Advisory Committee
• American Heart Association Elizabeth Barrett-Conner Award for Young Investigators Finalist
• Ronald D. Mann Best Paper Prize, Pharmacoepidemiology and Drug Safety

Research Interests

• Cardiovascular epidemiology
• Asian American health
• Atrial fibrillation
• Coronary heart disease
• Drug safety
• Proteomics
• Genomics
• Drug target discovery
• Epidemiologic methods

Dr. Floyd leads the University of Washington Cardiovascular Health Research Unit. His research, supported by several NIH grants, seeks to identify new causes of cardiovascular diseases using a variety of tools and methodologies, including epidemiological studies, genomics, proteomics, and artificial intelligence. He has leadership roles in several national NHLBI-funded studies of cardiovascular disease, including the Multi-ethnic Observational Study in American Asian and Pacific Islander Communities (MOSAAIC) and the Cardiovascular Health Study (CHS).

Funded Projects

Proteomic and Genomic Discovery of Targets for Atrial Cardiopathy-Related Cardiovascular Outcomes

R01HL1819

Proteomic profiling to identify mechanisms of susceptibility and resilience to cardiac dysfunction in Black Americans

R01HL172495

Infrastructure for mentored access to CHS data and specimens

R01HL172803

Proteomic discovery in an inception cohort of acute myocardial infarction survivors

R01HL148701

Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study

R01HL142599

Hawaiian, Asian American, and Pacific Islander (HAAPI) Coordinating Center

U24HL169645